Triple-negative breast cancer (TNBC) is defined by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)—key molecular markers that are routinely utilized for breast cancer classification and therapeutic decision-making [27]. This evidence concerns the gene ESR1 and breast cancer.